We serve Chemical Name:Chloropyramine CAS:59-32-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Chloropyramine
CAS.NO:59-32-5
Synonyms:Chlorneoantergan;Avapena;Halopyramine;Anaphylline;Suprastin;Synpen;N-[(4-chlorophenyl)methyl]-N-[2-(dimethylamino)ethyl]pyridin-2-amine;Synopen;N-(4-Chlor-benzyl)-N’,N’-dimethyl-N-<2>pyridyl-ethylendiamin;N-[(4-chlorophenyl)methyl]-N’,N’-dimethyl-N-2-pyridinyl-1,2-ethanediamine;Chloropyramine;Chlorpyraminum;N-(4-Chlor-benzyl)-N’,N’-dimethyl-N-[2]pyridyl-aethylendiamin;Chlorpyramine;N-(4-chloro-benzyl)-N’,N’-dimethyl-N-[2]pyridyl-ethylenediamine;EINECS 200-421-1
Molecular Formula:C16H20ClN3
Molecular Weight:289.80300
HS Code:
Physical and Chemical Properties:
Melting point:25°C
Boiling point:413.5ºC at 760 mmHg
Density:1.158g/cm3
Index of Refraction:1.6
PSA:19.37000
Exact Mass:289.13500
LogP:3.30320
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Chlorneoantergan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 200-421-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pyridyl-ethylendiamin Use and application,N-(4-chloro-benzyl)-N’,N’-dimethyl-N-[2]pyridyl-ethylenediamine technical grade,usp/ep/jp grade.
Related News: This further investment in enhanced facilities and continuous staff development provides the increased range of testing services required by the international biopharmaceutical industry. 2-Butene, 1,4-difluoro-2,3-dimethyl-, (Z)- manufacturers Liam McHale, site director for Charles River Ballina said: “We are incredibly proud of the transformational changes we have implemented on site and the role that Charles River has played in supporting the safe and timely rollout of AstraZeneca’s COVID-19 vaccine. (2S)-2-[[2-[(2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylamino]acetyl]amino]-3-phenylpropanoic acid suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. (Z)-2-((3,7-dimethyl-3,7-dihydro-6H-purin-6-ylidene)methyl)-3-methylnaphtho[2,3-d]thiazol-3-ium iodide vendor & factory.
